/ANGO

AngioDynamics Inc

ANGO

$15.27USD↑+0.20%+0.03 today

MARKET CAP

631.1M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$15 – $15

52W RANGE

$9

$16

AI Summary

Stalk

StalkMedium

Stage 2 advancing structure and active Momentum Breakout pattern confirm a bullish medium/long-term bias; however, price is extended above the short-term EMA band and in extreme overbought territory, making immediate execution unfavorable. Optimal engagement is deferred into pullbacks toward rising EMA support and prior resistance zones.

↑MedTech segment grew 19% YoY, comprising 47% of total revenue
↑Projected gross margins of 54%–55% in fiscal 2027 support profitability
↓Over 350 catheter lawsuits pose material financial and operational risk

Full analysis →

Buying

6

institutions

Selling

5

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	3.80 M	49.48 M	+117.33 K	+18.1%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	3.06 M	39.84 M	+-119.31 K	+10.1%	0.05%
MM Millennium Management LLC Q2 2026	BUY	783.12 K	10.19 M	+138.45 K	+39.0%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	733.88 K	9.55 M	+-69.40 K	+4.5%	0.01%
AC Aqr Capital Management LLC Q2 2026	BUY	589.16 K	7.66 M	+337.64 K	+168.0%	0.00%
JC Jpmorgan Chase & Co Q2 2026	BUY	220.78 K	2.91 M	+204.38 K	+1534.8%	0.00%
MC Moore Capital Management, LP Q2 2026	SELL	183.10 K	2.38 M	+-12.40 K	+7.2%	0.04%
BH Brevan Howard Capital Management LP Q2 2026	BUYNEW	13.87 K	180.40 K	+13.87 K	+0.0%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	12.48 K	162.42 K	+-52.54 K	-78.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	BUYNEW	12.12 K	157.75 K	+12.12 K	+0.0%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	313.00	4.07 K	+-350.00	-46.0%	0.00%